Current MS Treatment Paradigms
Key opinion leaders highlight the MS treatment landscape.
Financial Burden for Patients Diagnosed with MS
An expert panel discusses cost burden associated with the treatment of MS.
Individualized Care for Specific Patient Populations Elevating Outcomes in Women's Health
The panelists provide their final thoughts regarding disparities in women’s health.
Overview of Current HIV Treatment Strategies
The treatment landscape for HIV is discussed by a panel led by Dr Welch.
Guideline-Directed HIV Therapies
Key opinion leaders discuss the influence of guideline-directed therapy in the treatment of patients with HIV.
Navigating Vaccine Hesitancy
Vaccine hesitancy is a significant barrier to optimal RSV vaccine rollout.
Anticipating Needs of Patients Diagnosed with RSV
Experts discuss strategies to prepare for the oncoming respiratory diseases season.
Opportunities and Challenges Facing RSV Vaccination Rollouts
Dr Filer highlights the considerations for the rollout of new RSV vaccines.
MS Disease Activity Versus Inactivity
The pathophysiology and treatment of active and inactive MS are explored.
Overview of Multiple Sclerosis Epidemiology
Ryan Haumschild, PharmD, MS, MBA, leads a discussion around the epidemiology of multiple sclerosis.
Challenges with TNBC Influenced by Racial Disparities
Drs Derek van Amerongen, Soyini Hawkins, Roxie Cannon Wells, and Sharon Deans highlight triple-negative breast cancer among underrepresented patient populations.
Community-Based Screening Initiatives in Women's Health
The panel highlights initiatives to aid women in early cervical cancer diagnosis and intervention.
Social and Clinical Barriers Associated with HIV
An expert panel navigates stigmas and barriers inhibiting patients from achieving optimal care for HIV.
Barriers to Obtaining Optimal HIV Treatment
Dr Adam C. Welch drives a discussion highlighting disparities in health care equity affecting patients who receive an HIV diagnosis.
RSV Outcomes in Infant, Pediatric, and Adult Patient Populations
Wanda Filer, MD, MBA, FAAFP, provides an overview of the potential outcomes for patients of all ages with RSV.
Clinical Trials Surrounding Effectiveness of RSV Vaccine
Key opinion leaders discuss ongoing clinical trials for respiratory syncytial virus vaccines.
Clinical Goals for Treating RSV
The panel discusses potential therapy options for adults infected with respiratory syncytial virus.
Collaborative Care and Patient Education Driving AD Treatment Pathways
In their final thoughts, medical experts highlight key considerations in the atopic dermatitis (AD) treatment landscape.
Medication Affordability Impacting AD Treatment Compliance
Amy Brennan underlines the impact of affordability and how it may be inhibiting the patient atopic dermatitis (AD) treatment process.
Cervical and Breast Cancers Affected by Racial Disparities
Key opinion leaders provide insight on the effect of racial disparities on patients with cervical and breast cancer.
Initiatives to Reduce Maternal Mortality: Part 2
Experts expand on racial and social factors influencing maternal mortality.
Payor Considerations for Treatment of HIV
Payor considerations in the treatment of HIV are explored.
HIV Incidence and Prevalence
A panel of experts open a discussion surrounding the current disease landscape of HIV.
Financial Considerations in RRMM Treatment Landscape
In their closing thoughts, the panelists discuss financial considerations for treating patients with RRMM.
Establishing Adequate Patient Support Systems
Building strong support systems from both clinical and personal perspectives can drive optimal patient outcomes.
Barriers to Appropriate RRMM Care
Barriers to sufficient multiple myeloma treatment are explored.
Financial Burden Associated with RSV
Financial impacts associated with respiratory syncytial virus infection are highlighted.
Increasing Awareness of RSV Vaccines
Dr Welch leads a conversation regarding strategies to increase awareness of respiratory syncytial virus.
RSV Incidence and Prevalence
Wanda Filer, MD, MBA, FAAFP, discusses the prevalence of RSV.
Navigating Prior Authorization and Prescription Process for AD Treatment
Expert panelists discuss bridging communication between payers and providers in the AD treatment pathway.
